SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001178913-20-000395
Filing Date
2020-02-12
Accepted
2020-02-12 16:16:11
Documents
1
Group Members
ARKIN COMMUNICATIONS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk2023994.htm SC 13D/A 44675
  Complete submission text file 0001178913-20-000395.txt   45907
Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Filed by) CIK: 0001321178 (see all company filings)

Type: SC 13D/A

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89992 | Film No.: 20604302
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences